Lyme disease vaccine (Aventis Pasteur/MedImmune)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLyme disease vaccine (Aventis Pasteur/MedImmune)
Drug Alias NameDbpA (MedImmune/Aventis Pasteur)decorin binding protein (MedImmune/Aventis Pasteur)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLyme Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur SaMedimmune Llc
Active IndicationsN/A
Inactive IndicationsLyme Disease

Other Information

ATC CodeN/A
Related LinksN/A